No Data
Andon Health (002432.SZ): Plans to repurchase shares for 0.25 billion yuan to -0.5 billion yuan.
On March 26, Gelonghui reported that Andon Health (002432.SZ) announced its plan to repurchase a portion of its shares held by the general public through centralized bidding in the secondary market. The funds for the buyback will come from the company's own capital and a dedicated loan for repurchase. The total amount for this buyback will not be less than 0.25 billion yuan (inclusive) and not exceed 0.5 billion yuan (inclusive), with the share buyback price not exceeding 50 yuan per share (inclusive). Based on the lower limit of the buyback funds and the upper limit of the buyback share price, it is estimated that approximately 5,000,000 shares can be repurchased, accounting for about 1.0% of the company's current total share capital.
Andon Health Co., Ltd. (SZSE:002432) Stock Most Popular Amongst Individual Investors Who Own 56%, While Private Companies Hold 25%
HAITONG SEC: The respiratory multiplex testing market is expected to continue expanding. It is recommended to pay attention to InnoTek (688253.SH) and others.
HAITONG SEC estimates that under neutral expectations, there will be a market space of 8.1 billion yuan for in-house respiratory testing products.
Andon Health Co., Ltd.'s (SZSE:002432) Price Is Right But Growth Is Lacking
Andon Health (002432.SZ) has completed its repurchase period, accumulating a buyback of 5.93% of its shares.
Andon Health (002432.SZ) announced that as of February 20, 2025, the company's share repurchase period...
Guosen: Focus on AI + Medical, high-quality innovation, and value symbols with stable performance.
Guosen remains bullish on companies with differentiated innovation capabilities and overseas potential.
Insufficient Growth At Andon Health Co., Ltd. (SZSE:002432) Hampers Share Price
